Business
– Teva will pay $40 million for the lung disease drug developer and up to $125 million in milestone payments plus royalties. – –...
Hi, what are you looking for?
– Teva will pay $40 million for the lung disease drug developer and up to $125 million in milestone payments plus royalties. – –...
– – / By Alan Gallindoss / Global pharmaceutical company Pfizer announced today that Israeli company Teva Pharmaceuticals Industries and Indian generic drug manufacturer...
– May Have Led to a Number of Patient Deaths in France. – / By Alan Gallindoss / Pharmaceutical trade magazine “in-pharmetechnologist.com” has...
– BioLineRx has signed an agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd. (CTTQ) for the development and commercialization of BL-8030, an oral treatment...
– /By Ilan Shavit/ Pharmaceutical company Shire LLC announced on May 31st it has settled its litigation against Israeli company Teva Pharmaceutical’s US subsidiary,...
– Teva sold the sleeping pills in packaging for heart failure medication. – Photo: For Illustration only – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
– / By Ilan Shavit / Brainsway Ltd. (TASE:BRIN) announced today that it has received CE Mark enabling commercialization of its Deep TMS system...
– – / By Ilan Shavit / A bidding war has begun over Adcock Ingram Holdings Ltd. (AIP) spawned by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) bid as...
– – / By Adrian Filut/ Four of Israel’s biggest companies – Teva Pharmaceutical Industries Ltd.(NYSE: TEVA; TASE: TEVA), Israel Chemicals Ltd. (TASE: ICL), Iscar Ltd., and Check Point Software...
– Brainsway will unveil the Deep TMS for the US market at the American Psychological Association annual meeting in mid-May in San Francisco. –...